BUSINESS● LOW3h ago · Oct 19, 2026, 8:54 PM
Arcutis Biotherapeutics advances 11% to new 52-week high
Seeking Alpha Tech · global
Arcutis Biotherapeutics has seen its stock advance by 11%, reaching a new 52-week high. This indicates a significant positive financial performance for the company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS15m agoHong Kong to cement its role as a yuan bond hub by appealing to more sovereign borrowersSouth China Morning PostBUSINESS30m agoMusk says he will give SpaceX share to every kid in America kmbc.com · United States